What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos

1

Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers

2

Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge

3

Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more
Close

"Targeted Therapy Cocktail" Could Control, Perhaps Cure, Cancer

July 14, 2012, 12:00 PM
Cancer%20patient%20ss

What's the Latest Development?

By changing how clinicians battle cancer, Harvard medical researchers believe the disease could become manageable, if not curable. While cancer treatment has entered a relatively new stage of "targeted therapy", as opposed to chemotherapy, most treatments last just a few months before the cancer becomes resistant. Now, the Harvard researchers have pinpointed a gene which helps cancer cells develop resistance to the targeted drugs. Called the KRAS gene, it is present in approximately one in a million cancer cells, but begins to multiply rapidly once targeted therapy has killed the cancer cells without the KRAS gene. 

What's the Big Idea?

The conclusion of the research is that a one-drug cancer therapy will not work, and that medicine must be developed to attack the KRAS gene and the cancer cells it inhabits. "The treatment must be tailored to the patient, and must be based on the genetic makeup of the patient’s cancer. Perhaps even more importantly, said Martin Nowak, a professor of mathematics and of biology and director of the Program for Evolutionary Dynamics, the two drugs used simultaneously must not overlap: If a single mutation allows the cancer to become resistant to both drugs, the treatment will fail just as the single-drug therapy does."

Photo credit: Shutterstock.com

 

 

"Targeted Therapy Cocktail"...

Newsletter: Share: